1 All cause mortality to 14 days |
7 |
257 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.71 [0.38, 1.33] |
1.1 G‐CSF |
6 |
197 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.09 [0.52, 2.29] |
1.2 GM‐CSF |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.22 [0.05, 0.94] |
2 All cause mortality to 28 days |
5 |
194 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.51 [0.27, 0.98] |
2.1 G‐CSF |
4 |
134 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.63 [0.29, 1.39] |
2.2 GM‐CSF |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.33 [0.10, 1.11] |
3 All cause mortality to discharge |
5 |
178 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.53 [0.25, 1.16] |
3.1 G‐CSF |
4 |
118 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.78 [0.27, 2.21] |
3.2 GM‐CSF |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.33 [0.10, 1.11] |
4 Failure to correct neutropenia in those neutropenic at trial entry |
3 |
88 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.13 [0.04, 0.46] |
4.1 G‐CSF |
2 |
28 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.42 [0.07, 2.46] |
4.2 GM‐CSF |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.06 [0.01, 0.44] |
5 All cause mortality to 14 days, in those neutropenic at trial entry |
3 |
97 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.34 [0.12, 0.92] |
5.1 G‐CSF |
2 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.58 [0.14, 2.43] |
5.2 GM‐CSF |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.22 [0.05, 0.94] |
6 All cause mortality to 28 days, in those neutropenic at trial entry |
3 |
97 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.38 [0.16, 0.95] |
6.1 G‐CSF |
2 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.47 [0.12, 1.83] |
6.2 GM‐CSF |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.33 [0.10, 1.11] |
7 All cause mortality to discharge, in those neutropenic at trial entry |
3 |
97 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.38 [0.16, 0.95] |
7.1 G‐CSF |
2 |
37 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.47 [0.12, 1.83] |
7.2 GM‐CSF |
1 |
60 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.33 [0.10, 1.11] |
8 All cause mortality to 14 days, in those without known neutropenia at trial entry |
4 |
132 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.22 [0.50, 2.99] |
8.1 G‐CSF |
4 |
132 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.22 [0.50, 2.99] |
8.2 GM‐CSF |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |